Center for Scientific Review; Notice of Closed Meetings, 13908-13909 [2020-04781]
Download as PDF
<![CDATA[
13908
Federal Register / Vol. 85, No. 47 / Tuesday, March 10, 2020 / Notices
exist that justify the EUA, at which
point the FDA Commissioner may issue
an EUA if the criteria for issuance of
such an authorization under section 564
of the FD&C Act are met.
The Centers for Disease Control and
Prevention (CDC), HHS, requested that
the FDA, HHS, issue an EUA for
personal respiratory protective devices
to allow the Department to take
preparedness measures, based on
information currently available about
the virus that causes COVID–19. The
determination of a public health
emergency, and the declaration that
circumstances exist justifying
emergency use of personal respiratory
protective devices by the Secretary of
HHS, as described below, enable the
FDA Commissioner to issue an EUA for
respiratory protective devices for
emergency use under section 564 of the
FD&C Act.
II. Determination by the Secretary of
Health and Human Services
On February 4, 2020, pursuant to
section 564 of the FD&C Act, I
determined that there is a public health
emergency that has a significant
potential to affect national security or
the health and security of United States
citizens living abroad and that involves
a novel (new) coronavirus (nCoV) first
detected in Wuhan City, Hubei
Province, China in 2019 (2019–nCoV).
The virus is now named SARS–CoV–2,
which causes the illness COVID–19.
khammond on DSKJM1Z7X2PROD with NOTICES
III. Declaration of the Secretary of
Health and Human Services
On March 2, 2020, on the basis of my
determination of a public health
emergency that has a significant
potential to affect national security or
the health and security of United States
citizens living abroad and that involves
the novel (new) coronavirus, I declared
that circumstances exist justifying the
authorization of emergency use of
personal respiratory protective devices
during the COVID–19 outbreak,
pursuant to section 564 of the FD&C
Act, subject to the terms of any
authorization issued under that section.
Notice of the EUAs issued by the FDA
Commissioner pursuant to this
determination and declaration will be
provided promptly in the Federal
Register as required under section 564
of the FD&C Act.
Alex M. Azar II,
Secretary.
[FR Doc. 2020–04823 Filed 3–9–20; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
17:20 Mar 09, 2020
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Investigator Initiated
Extended Clinical Trial (R01 Clinical Trial
Required).
Date: March 24, 2020.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G53A,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Julio C. Aliberti, Ph.D.,
Scientific Review Officer, Immunology
Review Branch, Scientific Review Program,
Division of Extramural Activities, National
Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers
Lane, Room 3G53A, Rockville, MD 20892–
9823, 301–761–7322, julio.aliberti@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIH Support for
Conferences and Scientific Meetings (Parent
R13 Clinical Trial Not Allowed).
Date: April 6–8, 2020.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F21B,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Maryam Feili-Hariri,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F21B,
Bethesda, MD 20892–9834, (240) 669–5026,
haririmf@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 4, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–04782 Filed 3–9–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: March 4, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2020–04780 Filed 3–9–20; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Center for Scientific Review; Notice of
Closed Meetings
E:\FR\FM\10MRN1.SGM
10MRN1
Federal Register / Vol. 85, No. 47 / Tuesday, March 10, 2020 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–18–
901: Chronic, Non-Communicable Diseases
and Disorders Across the Lifespan: Fogarty
International Research Training Award.
Date: April 2, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR19–232:
NIGMS Mature Synchrotron Resources for
Structural Biology (P30).
Date: April 2, 2020.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Sudha Veeraraghavan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–435–1504,
sudha.veeraraghavan@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD19–
029: The Intersection of Sex and Gender
Influences on Health and Disease.
Date: April 2–3, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D.,
Scientific Review Officer, EMNR IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6182,
MSC 7892, Bethesda, MD 20892, 301 435–
2514, riverase@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–18–
884: Novel Approaches to Safe, NonInvasive, Real Time Assessment of Human
Placenta Development and Function Across
Pregnancy.
Date: April 2, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Andrew Maxwell Wolfe,
Scientific Review Officer, Center for
Scientific Review, NIH, 6701 Rockledge Dr.,
Room 6214, Bethesda, MD 20892, (301) 402–
3019, andrew.wolfe@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–18–
VerDate Sep<11>2014
17:20 Mar 09, 2020
Jkt 250001
884: Novel Approaches to Safe, NonInvasive, Real Time Assessment of Human
Placenta Development and Function Across
Pregnancy.
Date: April 2, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Hui Chen, MD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6164, Bethesda, MD 20892, 301–
435–1044, chenhui@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Radiation Therapeutics and Biology.
Date: April 2, 2020.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Syed M Quadri, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210,
MSC 7804, Bethesda, MD 20892, 301–435–
1211, quadris@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: STEM Education and Training.
Date: April 2, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: John H Newman, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222,
MSC 7808, Bethesda, MD 20892, (301) 435–
0628, newmanjh@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 4, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–04781 Filed 3–9–20; 8:45 am]
BILLING CODE 4140–01–P
ADVISORY COUNCIL ON HISTORIC
PRESERVATION
Notice of Advisory Council on Historic
Preservation Quarterly Business
Meeting
Advisory Council on Historic
Preservation.
ACTION: Notice of meeting.
AGENCY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
13909
Notice is hereby given that
the Advisory Council on Historic
Preservation (ACHP) will have its next
quarterly meeting on Friday, March 13,
2020.
SUMMARY:
The quarterly meeting will take
place on Friday, March 13, 2020 starting
at 8:30 a.m.
DATES:
The meeting will be held in
Room SR325 at the Russell Senate
Office Building at Constitution and
Delaware Avenues NE, Washington, DC.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Tanya DeVonish, 202–517–0205,
tdevonish@achp.gov.
The
Advisory Council on Historic
Preservation (ACHP) is an independent
federal agency that promotes the
preservation, enhancement, and
sustainable use of our nation’s diverse
historic resources, and advises the
President and the Congress on national
historic preservation policy. The goal of
the National Historic Preservation Act
(NHPA), which established the ACHP in
1966, is to have federal agencies act as
responsible stewards of our nation’s
resources when their actions affect
historic properties. The ACHP is the
only entity with the legal responsibility
to encourage federal agencies to factor
historic preservation into their decision
making. For more information on the
ACHP, please visit our website at
www.achp.gov.
The agenda for the upcoming
quarterly meeting of the ACHP is the
following:
SUPPLEMENTARY INFORMATION:
I. Chairman’s Welcome and Report
II. Swearing-in of New Member
III. ACHP Administrative Matters
IV. Historic Preservation Policy and Programs
V. Section 106 Issues
A. Digital Information Task Force
B. Section 3 Report Development
C. Leveraging Federal Historic Buildings
Workgroup
D. Regulations Updates
i. National Register Regulations
ii. NEPA Regulations
VI. Other Reports
VII. New Business
VIII. Adjourn
The meetings of the ACHP are open
to the public. If you need special
accommodations due to a disability,
please contact Tanya DeVonish, 202–
517–0205 or tdevonish@achp.gov, at
least seven (7) days prior to the meeting.
Authority: 54 U.S.C. 304102.
Dated: February 20, 2020.
Javier E. Marques,
General Counsel.
[FR Doc. 2020–04859 Filed 3–9–20; 8:45 am]
BILLING CODE 4310–K6–P
E:\FR\FM\10MRN1.SGM
10MRN1
]]>Agencies
[Federal Register Volume 85, Number 47 (Tuesday, March 10, 2020)]
[Notices]
[Pages 13908-13909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04781]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant
[[Page 13909]]
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-18-901: Chronic, Non-Communicable Diseases and Disorders
Across the Lifespan: Fogarty International Research Training Award.
Date: April 2, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Seetha Bhagavan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD
20892, (301) 237-9838, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR19-232: NIGMS Mature Synchrotron Resources for Structural
Biology (P30).
Date: April 2, 2020.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW, Washington, DC 20015.
Contact Person: Sudha Veeraraghavan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-435-1504,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-OD19-029: The Intersection of Sex and Gender Influences
on Health and Disease.
Date: April 2-3, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review
Officer, EMNR IRG, Center for Scientific Review, National Institutes
of Health, 6701 Rockledge Drive, Room 6182, MSC 7892, Bethesda, MD
20892, 301 435-2514, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-18-884: Novel Approaches to Safe, Non-Invasive, Real Time
Assessment of Human Placenta Development and Function Across
Pregnancy.
Date: April 2, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Andrew Maxwell Wolfe, Scientific Review Officer,
Center for Scientific Review, NIH, 6701 Rockledge Dr., Room 6214,
Bethesda, MD 20892, (301) 402-3019, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-18-884: Novel Approaches to Safe, Non-Invasive, Real Time
Assessment of Human Placenta Development and Function Across
Pregnancy.
Date: April 2, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Hui Chen, MD, Scientific Review Officer, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 6164, Bethesda, MD 20892, 301-435-1044,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Radiation Therapeutics and Biology.
Date: April 2, 2020.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Syed M Quadri, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301-435-
1211, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: STEM Education and Training.
Date: April 2, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: John H Newman, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3222, MSC 7808, Bethesda, MD 20892, (301) 435-
0628, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 4, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-04781 Filed 3-9-20; 8:45 am]
BILLING CODE 4140-01-P
